专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2005118626A3 PEPTIDES FOR INDUCING A CTL AND/OR HTL RESPONSE TO HEPATITIS C VIRUS 审中-公开
标题翻译：用于诱导针对HEPATITIS C病毒的CTL和/或HTL反应的肽
公开(公告)号：WO2005118626A3
公开(公告)日：2006-07-06
申请号：PCT/EP2005052457
申请日：2005-05-30
申请人： INNOGENETICS NV , PHARMEXA INC , DEPLA ERIK , BUYSE MARIE-ANGE , LASTERS IGNACE , DESMET JOHAN , MAERTENS GEERT , BAKER DENISE , CHESNUT ROBERT W , NEWMAN MARK , SETTE ALESSANDRO , SIDNEY JOHN , SOUTHWOOD SCOTT
发明人： DEPLA ERIK , BUYSE MARIE-ANGE , LASTERS IGNACE , DESMET JOHAN , MAERTENS GEERT , BAKER DENISE , CHESNUT ROBERT W , NEWMAN MARK , SETTE ALESSANDRO , SIDNEY JOHN , SOUTHWOOD SCOTT
IPC分类号： C07K14/18 , A61K38/16 , A61K39/00 , A61K39/295 , G01N33/576
CPC分类号： C07K14/005 , A61K39/00 , A61K39/12 , A61K39/29 , A61K2039/55566 , A61K2039/57 , C12N2770/24222 , C12N2770/24234
摘要： The present invention is directed to peptides, and nucleic acids encoding them, derived from the Hepatitis C Virus (HCV). The peptides are those which elicit a CTL and/or HTL response in a host. The invention is also directed to compositions and vaccines for prevention and treatment of HCV infection and diagnostic methods for detection of HCV exposure in patients.
摘要翻译：本发明涉及衍生自丙型肝炎病毒（HCV）的肽和编码它们的核酸。肽是在宿主中引起CTL和/或HTL应答的肽。本发明还涉及用于预防和治疗HCV感染的组合物和疫苗以及用于检测患者中HCV暴露的诊断方法。

2. 发明申请

WO2011003935A4 PARATHYROID HORMONE RELATED PROTEIN ANTAGONISTS 审中-公开
标题翻译：甲状旁腺激素相关蛋白拮抗剂
公开(公告)号：WO2011003935A4
公开(公告)日：2011-04-07
申请号：PCT/EP2010059713
申请日：2010-07-07
申请人： COMPLIX NV , LOVERIX STEFAN , DESMET JOHAN , LASTERS IGNACE , VANWETSWINKEL SOPHIE , VAN GELDER PATRICK
发明人： LOVERIX STEFAN , DESMET JOHAN , LASTERS IGNACE , VANWETSWINKEL SOPHIE , VAN GELDER PATRICK
IPC分类号： C07K1/00 , C07K7/08 , C07K14/00
CPC分类号： C07K14/001 , C07K14/635 , C07K2318/20 , G01N33/574 , G01N2333/635
摘要： The present invention relates to PTHrP-binding single-chain 3-stranded alpha-helical coiled coil molecules, denoted 'Alphabodies', nucleic acids encoding said Aiphabodies, host cells comprising said nucleic acids, as well as pharmaceutical compositions comprising said Alphabodies, and methods for the treatment, prevention and diagnosis of cancer using said Alphabodies.
摘要翻译：本发明涉及称为'Alphabodies'的PTHrP-结合单链3-链α-螺旋卷曲螺旋分子，编码所述Aiphabody的核酸，包含所述核酸的宿主细胞，以及包含所述Alphabody的药物组合物，以及方法用于使用所述Alphabody进行癌症的治疗，预防和诊断。

3. 发明申请

WO2004058807A3 MHC CLASS I RESTRICTED T-CELL STIMULATING PEPTIDES FROM HEPATITIS B VIRUS 审中-公开
标题翻译： MHC I类限制性T细胞来自乙型肝炎病毒的刺激肽
公开(公告)号：WO2004058807A3
公开(公告)日：2004-09-30
申请号：PCT/EP0313948
申请日：2003-12-09
申请人： ALGONOMICS N V , LASTERS IGNACE , DESMET JOHAN , STEGMANN TOON , CASTELEIN BERNARD
发明人： LASTERS IGNACE , DESMET JOHAN , STEGMANN TOON , CASTELEIN BERNARD
IPC分类号： C07K14/02 , A61K38/00 , A61K39/12 , A61K39/29 , C07K7/06
CPC分类号： C07K14/005 , A61K2039/5154 , A61K2039/5256 , A61K2039/53 , A61K2039/55555 , A61K2039/57 , C12N2730/10122
摘要： The present invention related to peptides which are suitable for inducing an immune response to HBV and to the use of said peptides for the preparations of vaccines, compositions and in methods of diagnosis. Said sequences of said peptides are predicted using a method of the invention.
摘要翻译：本发明涉及适用于诱导针对HBV的免疫应答的肽以及所述肽用于制备疫苗，组合物和诊断方法的用途。使用本发明的方法预测所述肽的所述序列。

4. 发明申请

WO0133438A3 METHOD FOR GENERATING INFORMATION RELATED TO THE MOLECULAR STRUCTURE OF A BIOMOLECULE 审中-公开
标题翻译：用于产生与生物分子的分子结构相关的信息的方法
公开(公告)号：WO0133438A3
公开(公告)日：2002-03-28
申请号：PCT/EP0010921
申请日：2000-11-03
申请人： ALGONOMICS NV , DESMET JOHAN , LASTERS IGNACE , VLIEGHE DOMINIQUE , BOUTTON CARLO , STAS PHILIPPE , SPRIET JAN
发明人： DESMET JOHAN , LASTERS IGNACE , VLIEGHE DOMINIQUE , BOUTTON CARLO , STAS PHILIPPE , SPRIET JAN
IPC分类号： C07K1/00 , C40B40/06 , C40B40/10 , C40B40/12 , G06F17/50 , G06F19/16 , G06F19/00
CPC分类号： G06F19/16 , B01J2219/00689 , B01J2219/00695 , B01J2219/007 , B01J2219/0072 , B01J2219/00722 , B01J2219/00725 , B01J2219/00731 , C07K1/00 , C07K2299/00 , C40B40/06 , C40B40/10 , C40B40/12
摘要： A method for generating information related to the molecular structure of a biomolecule, comprising the steps of: (a) receiving a three-dimensional representation of said molecular structure, comprising a first set of residue portions and a template; and (b) modifying the representation of step (a) by at least one optimization cycle. Each optimization cycle comprises the steps of: (b1) perturbing a first representation of the molecular structure by modifying the structure of one or more of the first set of residue portions; (b2) relaxing the perturbed representation by optimizing the structure of one or more of the non-perturbed residue portions of the first set with respect to the one or more perturbed residue portions; (b3) evaluating the perturbed and relaxed representation of the molecular structure by using an energetic cost function and replacing the first representation by the perturbed and relaxed representation if the latter's global energy is more optimal than that of the first representation; and the method further comprises the steps of (c) terminating the optimization process according to step (b) when a predetermined termination criterion is reached; and (d) outputting to a storage medium or to a consecutive method a data structure comprising information extracted from step (b).
摘要翻译：一种用于产生与生物分子的分子结构相关的信息的方法，包括以下步骤：（a）接收所述分子结构的三维表示，包括第一组残基部分和模板; 和（b）通过至少一个优化周期来修改步骤（a）的表示。每个优化周期包括以下步骤：（b1）通过修改第一组残留部分中的一个或多个的结构扰乱分子结构的第一表示; （b2）通过相对于一个或多个扰动残余部分优化第一组的非扰动残余部分的一个或多个的结构来放松扰动表示; （b3）通过使用能量成本函数来评估分子结构的扰动和松弛表示，并且如果后者的全局能量比第一表示更为优化，则通过扰动和轻松表示来代替第一表示; 并且所述方法还包括以下步骤：（c）当达到预定的终止标准时，终止根据步骤（b）的优化过程; 以及（d）向存储介质或连续方法输出包括从步骤（b）提取的信息的数据结构。

5. 发明申请

WO2011003935A9 PARATHYROID HORMONE RELATED PROTEIN ANTAGONISTS 审中-公开
公开(公告)号：WO2011003935A9
公开(公告)日：2011-06-03
申请号：PCT/EP2010059713
申请日：2010-07-07
申请人： COMPLIX NV , LOVERIX STEFAN , DESMET JOHAN , LASTERS IGNACE , VANWETSWINKEL SOPHIE , VAN GELDER PATRICK
发明人： LOVERIX STEFAN , DESMET JOHAN , LASTERS IGNACE , VANWETSWINKEL SOPHIE , VAN GELDER PATRICK
IPC分类号： C07K1/00 , C07K7/08 , C07K14/00
CPC分类号： C07K14/001 , C07K14/635 , C07K2318/20 , G01N33/574 , G01N2333/635
摘要： The present invention relates to PTHrP-binding single-chain 3-stranded alpha-helical coiled coil molecules, denoted 'Alphabodies', nucleic acids encoding said Aiphabodies, host cells comprising said nucleic acids, as well as pharmaceutical compositions comprising said Alphabodies, and methods for the treatment, prevention and diagnosis of cancer using said Alphabodies.

6. 发明申请

WO2009030780A3 NON-NATURAL PROTEINACEOUS SCAFFOLD MADE OF THREE NON-COVALENTLY ASSOCIATED PEPTIDES 审中-公开
标题翻译：由三种非共价相关肽制成的非天然蛋白质支架
公开(公告)号：WO2009030780A3
公开(公告)日：2009-04-30
申请号：PCT/EP2008061886
申请日：2008-09-08
申请人： COMPLIX NV , DESMET JOHAN , LASTERS IGNACE
发明人： DESMET JOHAN , LASTERS IGNACE
IPC分类号： C07K1/00 , C07K14/00
CPC分类号： C07K1/00 , C07K7/08 , C07K14/001 , C07K2318/20
摘要： The present invention is related to a non- natural, thermodynamically stable, proteinaceous scaffold consisting of three non-covalently associated peptides, wherein each peptide sequence comprises less than fifty amino acid residues and wherein at least 50% of the said residues are substitutable amino acids into at least ten different amino acid residue types. The present invention is further related to a non-natural, triple-stranded, parallel alpha-helical coiled coil scaffold wherein each of the three constituting peptide sequences comprise between 2 and 7 consecutive heptad repeats, wherein at least 50% of the core residues are isoleucines, wherein all non-core residues are alanines, and wherein the constituting peptide sequences remain associated under physical conditions that are significantly different from physiological conditions.
摘要翻译：本发明涉及由三种非共价缔合的肽组成的非天然的热力学稳定的蛋白质支架，其中每种肽序列包含少于五十个氨基酸残基，并且其中至少50％的所述残基是可取代的氨基酸转化成至少十种不同的氨基酸残基类型。本发明进一步涉及非天然的三链平行α-螺旋卷曲螺旋支架，其中三个构成肽序列中的每一个包含2-7个连续的七肽重复序列，其中至少50％的核心残基是其中所有非核心残基都是丙氨酸，并且其中组成的肽序列在与生理条件显着不同的物理条件下保持缔合。

7. 发明申请

WO2005103679A8 METHOD FOR AFFINITY SCORING OF PEPTIDE/PROTEIN COMPLEXES 审中-公开
标题翻译：肽/蛋白复合物的亲和性分选方法
公开(公告)号：WO2005103679A8
公开(公告)日：2006-03-02
申请号：PCT/BE2005000052
申请日：2005-04-21
申请人： ALGONOMICS NV , DESMET JOHAN , MEERSSEMAN GEERT , BOUTONNET NATHALIE , PLETINCKX JURGEN , DE CLERCQ KRISTA , LASTERS IGNACE
发明人： DESMET JOHAN , MEERSSEMAN GEERT , BOUTONNET NATHALIE , PLETINCKX JURGEN , DE CLERCQ KRISTA , LASTERS IGNACE
IPC分类号： G06F19/16 , G06F19/18
CPC分类号： G06F19/16 , G06F19/18

8. 发明申请

WO2004092207A2 RESPIRATORY SYNCYTIAL VIRUS (RSV) PEPTIDES 审中-公开
标题翻译：呼吸道同源性病毒（RSV）肽
公开(公告)号：WO2004092207A2
公开(公告)日：2004-10-28
申请号：PCT/EP2004004061
申请日：2004-04-16
申请人： ALGONOMICS N V , LASTERS IGNACE , DESMET JOHAN , STEGMANN TOON
发明人： LASTERS IGNACE , DESMET JOHAN , STEGMANN TOON
IPC分类号： A61K38/00 , A61K39/00 , C07K14/135 , G01N33/50 , G01N33/569 , A61K39/155 , C07K7/06
CPC分类号： G01N33/505 , A61K38/00 , A61K39/00 , A61K2039/53 , C07K14/005 , C12N2760/18522 , G01N33/56977 , G01N33/56983
摘要： The present invention relates to peptides which are suitable for inducing an immune response to RSV and to the use of said peptides for the preparations of vaccines, compositions and in methods of diagnosis.
摘要翻译：本发明涉及适用于诱导对RSV的免疫应答的肽以及用于制备疫苗，组合物和诊断方法的所述肽的用途。

9. 发明申请

WO0137147A3 APPARATUS AND METHOD FOR STRUCTURE-BASED PREDICTION OF AMINO ACID SEQUENCES 审中-公开
标题翻译：用于氨基酸序列的结构预测的装置和方法
公开(公告)号：WO0137147A3
公开(公告)日：2002-07-04
申请号：PCT/EP0010923
申请日：2000-11-03
申请人： ALGONOMICS NV , DESMET JOHAN , LASTERS IGNACE , VLIEGHE DOMINIQUE , BOUTTON CARLO , STAS PHILIPPE
发明人： DESMET JOHAN , LASTERS IGNACE , VLIEGHE DOMINIQUE , BOUTTON CARLO , STAS PHILIPPE
IPC分类号： G06F19/16 , G06F17/50 , G06F19/00
CPC分类号： G06F19/16
摘要： A. Receiving a reference (3D) structure for a protein. B. Substituting into the reference structure of step (A) a pattern, whereby the said pattern consists of one or more of the moduled residue positions defined in step (A), each carrying a particular amino acid residue type in a fixed conformation, and the one or more amino acid residue types of the said pattern are replacing the corresponding amino acid residue types present in the reference structure. C. Optimizing the global conformation of the reference structure of step (A) being substituted by the pattern of step (B). D. Assessing the energetic compatibility of the pattern defined in step (B) within the context of the reference structure defined in step (A) being structurally optimized in step (C) with respect to the said pattern, by way of comparing the global energy of the substituted and optimized protein structure with the global energy of the non-substituted reference structure.
摘要翻译： A.接收蛋白质的参考（3D）结构。 B.将步骤（A）的参考结构代入模式，其中所述模式由步骤（A）中定义的一个或多个模块化残基位置组成，每个载体具有固定构象的特定氨基酸残基类型，以及所述图案的一个或多个氨基酸残基类型替换参考结构中存在的相应氨基酸残基类型。 C.优化步骤（A）的参考结构的全局构象由步骤（B）的模式代替。 D.在步骤（C）中定义的参考结构的上下文中评估步骤（B）中定义的模式的能量相容性在步骤（C）中相对于所述模式在结构上优化，通过比较全局能量的取代和优化的蛋白质结构与未取代的参考结构的全局能量。

10. 发明专利

CA2566506A1 PEPTIDES FOR INDUCING A CTL AND/OR HTL RESPONSE TO HEPATITISC VIRUS 未知
公开(公告)号：CA2566506A1
公开(公告)日：2005-12-15
申请号：CA2566506
申请日：2005-05-30
申请人： INNOGENETICS NV , PHARMEXA INC
发明人： BUYSE MARIE-ANGE , LASTERS IGNACE , DESMET JOHAN , SETTE ALESSANDRO , MAERTENS GEERT , BAKER DENISE , SOUTHWOOD SCOTT , DEPLA ERIK , SIDNEY JOHN , NEWMAN MARK , CHESNUT ROBERT W
IPC分类号： C07K14/18 , A61K38/16 , A61K39/00 , A61K39/295 , G01N33/576
摘要： The present invention is directed to peptides, and nucleic acids encoding them, derived from the Hepatitis C Virus (HCV). The peptides are those which elicit a CTL and/or HTL response in a host. The invention is also directed to compositions and vaccines for prevention and treatment of HCV infection and diagnostic methods for detection of HCV exposure in patients.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式